Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Colestipol and Niacin



Research Papers that Mention the Interaction

The Cholesterol Lowering Atherosclerosis Study reported an increase in plasma homocyst(e)ine levels in patients receiving both colestipol and niacin compared with placebo.
American heart journal  •  1999  |  View Paper
BACKGROUND The Cholesterol Lowering Atherosclerosis Study, a controlled angiographic trial, has reported that new native coronary artery lesions are significantly reduced by aggressive blood lipid lowering therapy with colestipol plus niacin.
American journal of public health  •  1991  |  View Paper
Specifically, CLAS was designed to determine whether combined therapy with colestipol plus niacin will produce clinically significant change in coronary, carotid, and femoral artery atherosclerosis and coronary bypass graft lesions.
Controlled clinical trials  •  1987  |  View Paper
In contrast, serum cholesterol levels fell 45 per cent when colestipol as combined with niacin.
The New England journal of medicine  •  1981  |  View Paper
In the Cholesterol Lowering Atherosclerosis Study using colestipol plus nicotinic acid , it was demonstrated by quantitative coronary angiography that coronary artery plaque regression is achievable with statistical significance.
Angiology  •  2014  |  View Paper
The Cholesterol-Lowering Atherosclerosis Study demonstrated that combined therapy with a resin colestipol ) and nicotinic acid can reduce the progression of coronary atherosclerosis and the development of graft lesions in patients who have undergone coronary artery bypass graft surgery.
The American journal of cardiology  •  1990  |  View Paper
As prescribing of extended-release niacin increased, prescribing of colestipol , gemfibrozil, and probucol declined.
American journal of hospital pharmacy  •  1990  |  View Paper
When used as single agents, the bile-acid sequestrants, cholestyramine and colestipol , lower LDL cholesterol concentrations by 20% to 35% in compliant patients, whereas decreases of 20% to 30% can be achieved with nicotinic acid in doses of 3 to 6 g/day.
Arteriosclerosis  •  1989  |  View Paper
The socalled Cholesterol Lowering Atherosclerosis Study" was a randomized, placebo-controlled trial in which lipoprotein concentrations were altered markedly with combined treatment with colestipol and nicotinic acid.
The Medical journal of Australia  •  1988  |  View Paper
Plasma concentrations of LDL cholesterol declined 24% on colestipol ; the subsequent addition of nicotinic acid resulted in a further 31% fall so that values on the combined drug regimen were 47% below those seen on diet alone.
Treatment resulted in significant decreases in the LDL:HDL ratio which fell from 8.4 on diet to 3.3 on the colestipol plus nicotinic acid regimen.
The Lancet  •  1981  |  View Paper